← Open Payments lookup

MARVELLA GARCIA: Open Payments

NPI 1164145751 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,100 in 63 payments from 11 companies in 2025. Trend: 2023 $299 · 2024 $1,622 · 2025 $1,100

Food & beverage: $1,100
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$219
ABBVIE INC.17$170
Teva Pharmaceuticals USA, Inc.8$160
Otsuka America Pharmaceutical, Inc.11$153
Lundbeck LLC4$91
Takeda Pharmaceuticals U.S.A., Inc.4$74
Axsome Therapeutics, Inc.3$59
E.R. Squibb & Sons, L.L.C.3$59
Janssen Pharmaceuticals, Inc2$54
Neurocrine BioSciences, Inc.1$39

Products named: REXULTI, CAPLYTA, VRAYLAR, UZEDY, TRINTELLIX, Auvelity, COBENFY, SPRAVATO.

Industry payments across TX — which companies pay providers there.